18F-FDG PET and PET/CT patient preparation: a review of the literature
DS Surasi, P Bhambhvani, JA Baldwin… - Journal of nuclear …, 2014 - Soc Nuclear Med
For many types of cancer, 18 F-FDG PET/CT is commonly used in evaluation and management,
including tumor diagnosis, staging, restaging, treatment monitoring, and radiation …
including tumor diagnosis, staging, restaging, treatment monitoring, and radiation …
99mTc-Tilmanocept: a novel molecular agent for lymphatic mapping and sentinel lymph node localization
DS Surasi, J O'Malley… - Journal of nuclear …, 2015 - Soc Nuclear Med
Preoperative lymphatic mapping in conjunction with intraoperative γ-probe detection is widely
used for sentinel node localization in melanoma, breast cancer, and other malignancies. …
used for sentinel node localization in melanoma, breast cancer, and other malignancies. …
[HTML][HTML] Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate-to very …
DS Surasi, M Eiber, T Maurer, MA Preston, BT Helfand… - European urology, 2023 - Elsevier
… Financial disclosures: Devaki Shilpa Surasi certifies that all conflicts of interest, including …
, or pending), are the following: Devaki Shilpa Surasi reports research support from Blue Earth …
, or pending), are the following: Devaki Shilpa Surasi reports research support from Blue Earth …
[HTML][HTML] Imaging of neuroendocrine prostatic carcinoma
Simple Summary Neuroendocrine prostate cancer (NEPC) is an aggressive type of prostate
cancer with a very high potential for distant metastatic spread in the body. It is associated …
cancer with a very high potential for distant metastatic spread in the body. It is associated …
[HTML][HTML] Association of high-intensity exercise with renal medullary carcinoma in individuals with sickle cell trait: clinical observations and experimental animal studies
…, M Soeung, L Perelli, E Dondossola, DS Surasi… - Cancers, 2021 - mdpi.com
Simple Summary Renal medullary carcinoma (RMC) is a rare but highly aggressive malignancy
that affects individuals of African descent with sickle cell trait (SCT). The driver of RMC …
that affects individuals of African descent with sickle cell trait (SCT). The driver of RMC …
[HTML][HTML] Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse …
…, R Goswamy, TK Bathala, DS Surasi… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Immune checkpoint therapy (ICT) prolongs survival in subsets of patients with
cancer but can also trigger immune-related adverse events (irAEs) requiring treatment …
cancer but can also trigger immune-related adverse events (irAEs) requiring treatment …
Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma
NR Wilson, AJ Wiele, DS Surasi, P Rao, K Sircar… - Clinical Genitourinary …, 2021 - Elsevier
Introduction Renal medullary carcinoma (RMC) is a rare and lethal renal cell carcinoma
characterized by the loss of tumor suppressor SMARCB1. Molecular profiling studies have …
characterized by the loss of tumor suppressor SMARCB1. Molecular profiling studies have …
[HTML][HTML] Efficacy and safety of bevacizumab plus erlotinib in patients with renal medullary carcinoma
AJ Wiele, DS Surasi, P Rao, K Sircar, X Su, TK Bathala… - Cancers, 2021 - mdpi.com
Simple Summary Renal medullary carcinoma (RMC) is a rare and highly aggressive renal
cell carcinoma, with a median survival of 13 months. Platinum-based chemotherapy is the …
cell carcinoma, with a median survival of 13 months. Platinum-based chemotherapy is the …
[HTML][HTML] Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune …
AW Hahn, DS Surasi, PV Viscuse, TK Bathala… - The …, 2023 - academic.oup.com
Background Metastatic RCC with sarcomatoid and/or rhabdoid (S/R) dedifferentiation is an
aggressive disease associated with improved response to immune checkpoint therapy (ICT). …
aggressive disease associated with improved response to immune checkpoint therapy (ICT). …
The association of periprostatic fat and grade group progression in men with localized prostate cancer on active surveillance
JR Gregg, DS Surasi, A Childs, N Moll… - The Journal of …, 2021 - auajournals.org
Purpose: Evidence suggests that visceral fat quantity may be associated with post-prostatectomy
outcomes and risk of prostate cancer related death. We evaluated whether increased …
outcomes and risk of prostate cancer related death. We evaluated whether increased …